{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:23:47Z","timestamp":1790663027449,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004563","type":"journal-article","created":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T13:30:50Z","timestamp":1458912650000},"page":"e0004563","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Antibody Profiling in Na\u00efve and Semi-immune Individuals Experimentally Challenged with Plasmodium vivax Sporozoites"],"prefix":"10.1371","volume":"10","author":[{"given":"Myriam","family":"Ar\u00e9valo-Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lopez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Dotsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Rubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Huw","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f3crates","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,25]]},"reference":[{"key":"ref1","unstructured":"WHO. World Malaria Report 2015. Geneva: WHO, 2015."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00025-08","article-title":"Acquired immunity to malaria","volume":"22","author":"DL Doolan","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"15","key":"ref3","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1073\/pnas.1001323107","article-title":"A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray","volume":"107","author":"PD Crompton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/IAI.01585-07","article-title":"Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria","volume":"76","author":"FH Osier","year":"2008","journal-title":"Infect Immun"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrmicro3364","article-title":"Asymptomatic malaria infections: detectability, transmissibility and public health relevance","volume":"12","author":"T Bousema","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12936-015-0678-3","article-title":"Clinical profile of <italic>Plasmodium falciparum<\/italic> and <italic>Plasmodium vivax<\/italic> infections in low and unstable malaria transmission settings of Colombia","volume":"14","author":"M Arevalo-Herrera","year":"2015","journal-title":"Malar J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12936-015-0711-6","article-title":"High prevalence of sub-microscopic infections in Colombia","volume":"14","author":"AF Vallejo","year":"2015","journal-title":"Malar J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2875-11-29","article-title":"The complexities of malaria disease manifestations with a focus on asymptomatic malaria","volume":"11","author":"DD Laishram","year":"2012","journal-title":"Malar J"},{"key":"ref9","first-page":"81","article-title":"Malaria: Drugs, Disease and Post-genomic Biology. Current Topics in Microbiology and Immunology 295","author":"MP Grobusch","year":"2005"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1475-2875-12-294","article-title":"High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms","volume":"12","author":"FG Versiani","year":"2013","journal-title":"Malar J"},{"issue":"22","key":"ref11","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1002\/pmic.200800194","article-title":"Profiling humoral immune responses to P. falciparum infection with protein microarrays","volume":"8","author":"DL Doolan","year":"2008","journal-title":"Proteomics"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"DH Davies","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.jprot.2011.10.018","article-title":"Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response","volume":"75","author":"S Ray","year":"2012","journal-title":"J Proteomics"},{"issue":"2 Suppl","key":"ref14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2011.09-0516","article-title":"Phase I safety and immunogenicity trial of <italic>Plasmodium vivax<\/italic> CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51","volume":"84","author":"S Herrera","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"24","key":"ref15","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for <italic>Plasmodium vivax<\/italic> malaria","volume":"23","author":"EM Malkin","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51","volume":"3","author":"Y Wu","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/hv.6.1.9931","article-title":"Current status of Plasmodium vivax vaccine","volume":"6","author":"M Arevalo-Herrera","year":"2010","journal-title":"Hum Vaccin"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2015.06.008","article-title":"Malaria vaccine clinical trials: what&apos;s on the horizon","volume":"35","author":"A Moreno","year":"2015","journal-title":"Curr Opin Immunol"},{"issue":"52","key":"ref19","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1016\/j.vaccine.2015.09.060","article-title":"Development of vaccines for Plasmodium vivax malaria","volume":"33","author":"I Mueller","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4269\/ajtmh.2009.09-0194","article-title":"Successful sporozoite challenge model in human volunteers with <italic>Plasmodium vivax<\/italic> strain derived from human donors","volume":"81","author":"S Herrera","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"2 Suppl","key":"ref21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4269\/ajtmh.2011.09-0498","article-title":"Consistent safety and infectivity in sporozoite challenge model of <italic>Plasmodium vivax<\/italic> in malaria-naive human volunteers","volume":"84","author":"S Herrera","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"e99754","DOI":"10.1371\/journal.pone.0099754","article-title":"Plasmodium vivax sporozoite challenge in malaria-naive and semi-immune Colombian volunteers","volume":"9","author":"M Arevalo-Herrera","year":"2014","journal-title":"PLoS One"},{"key":"ref23","unstructured":"International Conference on Harmonisation. ICH Harmonised Tripartite Guideline\u2014Guideline for Good Clinical Practice E6 (R1). 1996."},{"key":"ref24","article-title":"Gu\u00eda para atenci\u00f3n cl\u00ednica integral del paciente con malaria","year":"2010"},{"issue":"3 Suppl","key":"ref25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4269\/ajtmh.15-0037","article-title":"Biosignatures of Exposure\/Transmission and Immunity","volume":"93","author":"CL King","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1074\/mcp.M114.044677","article-title":"RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites","volume":"14","author":"JJ Campo","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2164-9-488","article-title":"BioVenn\u2014a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams","volume":"9","author":"T Hulsen","year":"2008","journal-title":"BMC Genomics"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1590\/S1020-49892000001100001","article-title":"Cryptosporidiosis in the Andean region of Colombia: seroprevalence and recognition of antigens","volume":"8","author":"C Vergara Castiblanco","year":"2000","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4142\/jvs.2013.14.2.107","article-title":"Sporozoite proteome analysis of Cryptosporidium parvum by one-dimensional SDS-PAGE and liquid chromatography tandem mass spectrometry","volume":"14","author":"AZ Siddiki","year":"2013","journal-title":"J Vet Sci"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"M111 007948","DOI":"10.1074\/mcp.M111.007948","article-title":"Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens","volume":"10","author":"A Trieu","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"5 Suppl","key":"ref31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4269\/ajtmh.2005.73.16","article-title":"Antigenicity, immunogenicity, and protective efficacy of <italic>Plasmodium vivax<\/italic> MSP1 PV200l: a potential malaria vaccine subunit","volume":"73","author":"A Valderrama-Aguirre","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12916-014-0150-1","article-title":"Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis","volume":"12","author":"JC Cutts","year":"2014","journal-title":"BMC Med"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"e2498","DOI":"10.1371\/journal.pntd.0002498","article-title":"Naturally acquired immune responses to P. vivax merozoite surface protein 3alpha and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children","volume":"7","author":"DI Stanisic","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/IAI.74.5.2726-2733.2006","article-title":"A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1","volume":"74","author":"PA Nogueira","year":"2006","journal-title":"Infect Immun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1038\/srep03549","article-title":"Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis","volume":"3","author":"PL Felgner","year":"2013","journal-title":"Sci Rep"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T17:55:26Z","timestamp":1540317326000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004563"}},"subtitle":[],"editor":[{"given":"Photini","family":"Sinnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,25]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004563","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,25]]}}}